Skip to main content
OpenTrials

Clinical trial condition

Meningeal Neoplasms

Explore clinical trials studying Meningeal Neoplasms. Study availability and eligibility vary by location and protocol.

277 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Meningeal Neoplasms trial results

Recruiting

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

NCT07428616

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +10 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Mayo Clinic_Arizona Phoenix, Arizona, United States
  • Mayo Clinic_Jacksonville Jacksonville, Florida, United States
  • Baptist Health Miami Cancer Institute Miami, Florida, United States
View all 17 locations
View Trial Details
Recruiting

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

NCT06955169

Conditions
Central Nervous System Neoplasms, Intracranial Meningioma, Meningeal Neoplasms, +8 more
Locations
  • University of California, Irvine Irvine, California, United States
  • University of California San Diego - Moores Cancer Center La Jolla, California, United States
  • Yale University New Haven, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
View all 16 locations
View Trial Details
Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

NCT04374305

Conditions
Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +38 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of Miami Miami, Florida, United States
  • Indiana University School of Medicine Indianopolis, Indiana, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Recruiting

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

NCT02523014

Conditions
Central Nervous System Neoplasms, Intracranial Meningioma, Meningeal Neoplasms, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 783 locations
View Trial Details
Recruiting

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

NCT06500481

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +21 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • UC San Diego Health System - Encinitas Encinitas, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 58 locations
View Trial Details
Recruiting

Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer

NCT06518057

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +21 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
View Trial Details

Related conditions